St. Jude Medical Announces CE Mark And Launch Of First Quadripolar CRT Pacemaker
Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). This CRT-P system offers more pacing options to deliver higher success rates, as evidenced by robust clinical data. Allure Quadra CRT-P brings the quadripolar lead technology to the pacemaker market for the first time... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 2, 2013 Category: Consumer Health News Tags: Medical Devices / Diagnostics Source Type: news

St. Jude Medical Announces CE Mark and Launch of First Quadripolar CRT Pacemaker
Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers ST. PAUL, Minn.--(Healthcare Sales & Marketing Network)--St. Jude Medical, Inc. (STJ), a global medical device company, today announced CE Mark approval and European l... Devices, Cardiology, Regulatory, Product LaunchSt. Jude Medical, Allure Quadra, CRT-P, quadripolar, pacemaker (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 30, 2013 Category: Pharmaceuticals Source Type: news

St. Jude Medical Announces CE Mark And Launch Of First Quadripolar CRT Pacemaker
Allure Quadra elevates the standard for Cardiac Resynchronization Therapy Pacemakers St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark approval and European launch of its Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker (CRT-P). The first-to-market quadripolar CRT-P system allows for increased implant efficiencies that result in fewer surgical revisions, and offers more pacing options to deliver higher success rates, as evidenced by robust clinical data... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 30, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

Conflicting Results From Two Trials Of Cardiac Resynchronization Therapy
Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval.  The positive results of the smaller trial seem likely to be undermined by the early stopping of the much larger trial. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 25, 2013 Category: Pharmaceuticals Authors: Larry Husten Source Type: news

Weight Loss In Patients With Implanted Defibrillators Predicts Worse Health Outcomes
Even minor weight loss is associated with worse health outcomes among patients implanted with a certain type of defibrillator known as cardiac resynchronization therapy with defibrillator (CRT-D), according to research presented at the American College of Cardiology's 62nd Annual Scientific Session. People with symptoms of heart failure who have an implantable CRT-D device may believe that losing weight will ultimately improve their long-term health outcomes... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 11, 2013 Category: Consumer Health News Tags: Heart Disease Source Type: news

Appropriate Use Criteria For ICDs And CRT
The American College of Cardiology and the Heart Rhythm Society, along with key specialty societies, have released appropriate use criteria for implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT). The document provides assessed levels of appropriateness for implanting the devices in 369 real-life clinical scenarios, with the goal of enhancing physician and patient decision making and improving care and health outcomes... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 4, 2013 Category: Consumer Health News Tags: Cardiovascular / Cardiology Source Type: news

ACC/HRS release appropriate use criteria for ICDs and CRT
(American College of Cardiology) The American College of Cardiology and the Heart Rhythm Society, along with key specialty societies, today released appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. The document provides assessed levels of appropriateness for implanting the devices in 369 real-life clinical scenarios, with the goal of enhancing physician and patient decision making and improving care and health outcomes. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 28, 2013 Category: Global & Universal Source Type: news

CRT-D Benefits Those with Higher Ejection Fraction (CME/CE)
(MedPage Today) -- Physicians may have to rethink the left ventricular ejection fraction (LVEF) cutoff for eligibility for cardiac resynchronization therapy with defibrillation (CRT-D) as a new analysis showed good results in patients with mild heart failure and LVEF greater than 30%. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 25, 2013 Category: Cardiology Source Type: news

Cardiac Resynchronization Dangerous With Narrow QRSCardiac Resynchronization Dangerous With Narrow QRS
Cardiac resynchronization therapy (CRT) does not help heart failure patients with QRS complex less than 120 msec, and in fact might hurt them, the LESSER-EARTH trial has shown. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Cardiac Resynchronization Therapy in SeniorsCardiac Resynchronization Therapy in Seniors
Fresh perspectives are offered regarding cardiac device implantation for senior citizens. European Journal of Heart Failure (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

CRT May Help in Some Cases of Cardiomyopathy (CME/CE)
(MedPage Today) -- Some patients have a cardiomyopathy induced by left bundle branch block in the absence of structural heart disease that can be resolved with cardiac resynchronization therapy, a retrospective study suggested. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - January 25, 2013 Category: Cardiology Source Type: news